outbreak
coronaviru
diseas
caus
novel
sever
acut
respiratori
syndrom
coronaviru
remain
huge
threat
public
health
worldwid
clinic
data
limit
regard
risk
factor
favor
sever
convers
nonsever
case
aim
studi
analyz
hospit
staff
data
figur
gener
clinic
featur
term
associ
cardiovascular
manifest
cvm
inhospit
outcom
case
method
retrospect
singlecent
case
seri
consecut
hospit
health
staff
confirm
collect
clinic
laboratori
radiolog
treatment
data
inhospit
advers
event
collect
analyz
final
date
followup
march
compar
studi
appli
case
cvm
without
cvm
result
clinician
clinic
nurs
account
histori
patient
contact
popul
present
mean
age
less
comorbid
commun
popul
three
frequent
symptom
case
analyz
fever
myalgia
fatigu
cough
three
frequent
initi
symptom
myalgia
fatigu
fever
cough
case
featur
nonsever
cours
diseas
accord
offici
standard
china
patient
cvm
without
cvm
account
respect
compar
case
without
cvm
patient
cvm
present
lower
baselin
lymphocyt
count
p
least
posit
nucleic
acid
detect
throat
swab
admiss
receiv
oxygen
support
p
rate
inhospit
advers
event
significantli
higher
patient
cvm
group
multivari
logist
regress
model
indic
coexist
cvm
patient
independ
associ
clinic
experi
increas
clinician
becom
consciou
cardiovascular
comorbid
manifest
two
report
show
patient
hypertens
coronari
arteri
diseas
wors
inhospit
outcom
cardiovascular
manifest
cvm
could
initi
present
appear
throughout
whole
cours
liu
et
al
analyz
case
found
patient
complain
palpit
initi
symptom
account
first
report
case
admit
decemb
januari
reveal
acut
cardiac
injuri
occur
patient
wang
et
al
report
singlecent
case
seri
involv
patient
also
found
cardiovascular
complic
rare
among
arrhythmia
acut
cardiac
injuri
account
respect
level
hypersensit
troponin
admiss
significantli
higher
admit
intens
care
unit
icu
compar
studi
appli
explain
whether
concomit
cvm
effect
inhospit
outcom
case
retrospect
studi
data
analysi
perform
anonym
requir
inform
consent
waiv
ethic
committe
central
hospit
wuhan
approv
studi
group
staff
central
hospit
wuhan
confirm
admit
pneumolog
depart
central
hospit
wuhan
januari
januari
enrol
oral
consent
obtain
patient
central
hospit
wuhan
locat
wuhan
hubei
provinc
endem
area
one
major
tertiari
teach
hospit
affili
medic
record
patient
collect
databas
research
central
hospit
wuhan
electron
medic
record
system
epidemiolog
clinic
characterist
laboratori
radiolog
find
treatment
outcom
data
firsthand
obtain
data
review
train
team
physician
inform
record
includ
demograph
data
medic
histori
exposur
histori
comorbid
symptom
sign
laboratori
find
chest
comput
tomograph
ct
scan
nucleic
acid
detect
throat
swab
treatment
measur
inhospit
advers
event
date
diseas
onset
defin
day
symptom
notic
treatment
includ
antivir
therapi
antibiot
antifungu
drug
corticosteroid
therapi
intraven
human
albumin
immunoglobulin
thymosin
tradit
chines
medicin
mesenchym
stem
cell
therapi
respiratori
support
none
receiv
kidney
replac
therapi
plasma
exchang
artifici
liver
respiratori
failur
rf
diagnos
accord
arteri
blood
ga
analysi
hospit
advers
event
includ
rf
ard
transfer
icu
invas
mechan
ventil
acut
cardiac
injuri
aki
acut
hepat
injuri
acut
myocyt
injuri
shock
secondari
infect
death
case
cvm
defin
one
throughout
cours
diseas
complain
palpit
chest
distress
elev
creatin
kinasemb
hypersensit
cardiac
troponin
percentil
upper
refer
limit
new
abnorm
electrocardiographi
includ
sinu
tachycardia
throat
swab
sampl
collect
extract
ribos
nucleic
acid
rna
patient
suspect
clinic
diagnosi
miraclean
technolog
co
ltd
shenzhen
china
collect
throat
swab
place
collect
tube
viru
preserv
solut
total
rna
extract
use
respiratori
sampl
rna
isol
kit
autom
nucleic
acid
extract
system
shanghai
zj
biotech
co
ltd
china
suspens
use
realtim
data
statist
appli
use
spss
ibm
corp
armonk
new
york
usa
student
ttest
use
compar
continu
variabl
conform
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
normal
distribut
chisquar
test
appli
compar
categor
variabl
two
group
multivari
logist
regress
analys
appli
control
baselin
confound
covari
logist
regress
variabl
signific
differ
two
group
baselin
p
valu
two
side
signific
level
tendenc
signific
differ
judg
p
studi
popul
includ
hospit
staff
confirm
mean
age
year
men
clinician
clinic
nurs
direct
contact
patient
account
respect
case
medic
detect
depart
account
also
contact
patient
specimen
case
administr
logist
depart
mostli
contact
infect
colleagu
recal
epidemiolog
histori
could
tell
infect
definit
histori
patient
contact
account
suspect
histori
patient
contact
account
case
told
contact
infect
famili
member
also
contact
suspect
patient
make
clue
question
tabl
young
middleag
popul
mostli
gener
healthi
present
less
comorbid
gener
commun
popul
previous
report
comorbid
high
incid
elderli
like
diabet
mellitu
dm
hypertens
coronari
arteri
diseas
cad
chronic
obstruct
pulmonari
diseas
copd
malign
tumor
lower
three
frequent
symptom
case
analyz
studi
fever
myalgia
fatigu
cough
three
frequent
initi
symptom
myalgia
fatigu
fever
cough
furthermor
symptom
cours
diseas
includ
sputum
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
product
wheez
dyspnea
chilli
shiver
diarrhea
dizzi
somnipathi
rhinobyon
run
nose
headach
bloodi
sputum
conjunct
tabl
mean
white
blood
cell
wbc
count
case
wbc
count
account
mean
lymphocyt
count
case
lymphocyt
count
account
case
procalcitonin
ngml
account
tabl
enrol
patient
show
bilater
involv
chest
comput
tomographi
ct
scan
first
time
sinc
onset
case
bilater
involv
chest
ct
scan
admiss
account
lower
percentag
previous
report
tabl
figur
case
receiv
least
twice
nucleic
acid
detect
throat
swab
admiss
normal
temperatur
day
improv
respiratori
symptom
obviou
absorpt
pulmonari
inflamm
radiographi
well
twice
neg
nucleic
acid
detect
throat
swab
interv
hour
releas
quarantin
discharg
accord
diagnosi
tabl
case
receiv
least
one
kind
antivir
drug
empir
includ
oseltamivir
ribavirin
arbidol
lopinavirritonavir
kaletra
access
clinic
china
antibiot
antifungu
drug
appli
case
regard
confirm
secondari
infect
prevent
secondari
infect
rel
sever
case
corticosteroid
use
case
control
immun
overreact
human
albumin
appli
serum
albumin
decreas
immunoglobulin
also
appli
empir
well
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
thymosin
case
receiv
chines
tradit
medicin
account
includ
patent
medicin
prescript
case
march
receiv
mesenchym
stem
cell
therapi
inform
consent
one
firstli
consent
empir
therapi
day
symptom
onset
pulmonari
inflamm
poorli
absorb
ct
scan
figur
case
underw
respiratori
support
includ
oxygen
therapi
common
nasal
cathet
face
mask
common
nasal
cathet
face
mask
simultan
high
flow
nasal
cannula
mechan
ventil
one
case
suffer
irreform
hypoxemia
receiv
noninvas
ventil
support
later
transfer
icu
tracheal
intub
tabl
none
inhospit
death
none
suffer
acut
cardiac
injuri
aki
admiss
march
two
case
diagnos
rf
ard
tabl
among
case
analyz
patient
cvm
without
cvm
account
respect
compar
case
without
cvm
patient
cvm
present
lower
baselin
lymphocyt
count
p
least
posit
nucleic
acid
detect
throat
swab
admiss
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
multivari
logist
regress
model
indic
adjust
possibl
baselin
confound
concomit
cvm
independ
associ
inhospit
advers
event
ci
p
patient
baselin
lymphocyt
count
show
tendenc
signific
two
group
model
ci
p
tabl
analyz
popul
character
younger
age
less
comorbid
common
commun
patient
mostli
featur
nonsever
cours
specif
antivir
drug
infect
expect
mainli
come
evid
remdesivir
chloroquin
highli
effect
control
infect
vitro
cytotox
remain
control
report
remdesivir
nucleotid
analogu
prodrug
previous
clinic
develop
treatment
ebola
viru
diseas
exhibit
broadspectrum
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
authorfund
grant
medrxiv
licens
display
preprint
perpetu
authorfund
grant
medrxiv
licens
display
preprint
perpetu
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
data
express
mean
standard
deviat
count
percentag
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
data
express
count
percentag
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
data
express
count
percentag
covari
possibl
confound
show
signific
differ
tendenc
signific
differ
group
baselin
analysi
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
